Bogart Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Bogart Wealth's VRTX Position: Q3 2026 in Review
Bogart Wealth increased its Vertex Pharmaceuticals (VRTX) stake by 0.21% in Q3 2026, buying an estimated $29.7K and bringing the position to 27,761 shares worth $14.5M. The position accounts for 0.48% of the portfolio, ranked #50.
Bogart Wealth first reported a position in VRTX in Q2 2022 and has held it in 18 quarters since. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Bogart Wealth held 27,761 shares of Vertex Pharmaceuticals worth $14.5M as of Q3 2026.
- Bogart Wealth bought 58 Vertex Pharmaceuticals shares in Q3 2026, an estimated $29.7K.
- Vertex Pharmaceuticals made up 0.48% of Bogart Wealth's portfolio in Q3 2026, its #50 holding.
- Bogart Wealth first reported a position in Vertex Pharmaceuticals in Q2 2022 and has held it in 18 quarters since.
- 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.